- Prediction of Serum Neuritin and Neuron-specific Enolase for Prognosis in Patients with Traumatic Brain Injury combined with Spinal Cord Injury
Neuritin and enolase prediction for brain + spinal cord injury patients
Abstract
Abstract: Serum neuritin and neuron-specific enolase (NSE) have predictive value for the prognosis of patients with combined traumatic brain injury (TBI) and spinal cord injury (SCI). Studying their predictive effects has positive value for disease control and treatment. Sixty patients with combined TBI and SCI were recruited and rolled into three groups according to prognosis: Group I (n=42, favorable prognosis), Group II (n=11, poor prognosis), and Group III (n=7, death). Clinical indicators were compared between the groups, and the predictive value of different indicators for prognosis was analyzed. NSE and serum neuritin levels were considerably higher in Groups II and III than in Group I (P<0.05). Multivariate logistic regression analysis showed that hypotension, NSE, serum neuritin, S100β, and combined injuries to other organs were associated with poor prognosis in patients with combined TBI and SCI. The combination of NSE and neuritin had considerably higher sensitivity (Sen), specificity (Spe), and accuracy (Acc) in predicting prognosis (P<0.05). Serum neuritin and NSE have favorable predictive value for the prognosis of patients with combined TBI and SCI. They can be actively promoted in clinical practice
References
1. Arnason S, Molewijk K, Henningsson AJ, Tjernberg I, Skogman BH. Brain damage markers neuron-specific enolase (NSE) and S100B in serum in children with Lyme neuroborreliosis-detection and evaluation as prognostic biomarkers for clinical outcome. Eur J Clin Microbiol Infect Dis, 2022;41(7):1051-1057.
2. Garcia-Alix A, Arnaez J. Value of brain damage biomarkers in cerebrospinal fluid in neonates with hypoxic-ischemic brain injury. Biomark Med, 2022.
3. Amoo M, Henry J, O’Halloran PJ, Brennan P, Husien MB, Campbell M, Caird J, Javadpour M, Curley GF. S100B, GFAP, UCH-L1 and NSE as predictors of abnormalities on CT imaging following mild traumatic brain injury: a systematic review and meta-analysis of diagnostic test accuracy. Neurosurg Rev, 2022;45(2):1171-1193.
4. Bassa A, Sagués T, Porta-Casteràs D, Serra P, Martínez-Amorós E, Palao DJ, Cano M, Cardoner N. The neurobiological basis of cognitive side effects of electroconvulsive therapy: a systematic review. Brain Sci, 2021;11(10):1273.
5. Lehrer S, Rheinstein PH. Vaccination reduces risk of alzheimer’s disease, parkinson’s disease, and other neurodegenerative disorders. Discov Med, 2022;34(172):97-101.
6. Wu XQ, Zhang XL, Wang YP, Qian SX, Guan QB, Lu XD, Yu XX. Peroxiredoxin 6 protects against oxidative stress and apoptosis in a rat model of lithiumchloride-pilocarpine-induced epilepsy. J Biol Regulat Homeost Agent, 2022;36(4):1017-1026.
7. Freni F, Galletti B, Bruno R, Martines F, Abita P, Francesco G, Sireci F, Galletti F. Multidisciplinary approach in the removal of post-trauma foreign bodies in the head and neck district: cases report and review of literature. Acta Med Mediterr, 2019;35(1):405-410.
8. Zeng Y, Wu D, Zhuo X, Song J. Effects of continuous blood purification without heparin on Strem-1, NSE, and IL-10 levels in patients with sepsis. Cell Mol Biol(Noisy-le-grand), 2022;68(4):178-187.
9. Zhang L, Wang Y, Pan RL, Li Y, Hu YQ, Xv H, Zhu C, Wang X, Yin JW, Ma KT, Zhao D. Neuritin attenuates oxygen-glucose deprivation/reoxygenation (OGD/R)-induced neuronal injury by promoting autophagic flux. Exp Cell Res, 2021;407(2):112832.
10. Hägglund L, Olivecrona M, Koskinen LD. Correlation of cerebral and subcutaneous glycerol in severe traumatic brain injury and association with tissue damage. Neurocrit Care, 2022;36(3):993-1001.
11. Ok M, Naseri A, Ates MB, Ider M, Uney K, Sevinc M, Hatipoglu F, Yildiz R, Erturk A, Baspinar N, Iyigun SS. The usefulness of serum brain damage biomarkers in detection and evaluation of hypoxic ischemic encephalopathy in calves with perinatal asphyxia. Animals(Basel), 2022;12(22):3223.
12. Silva RC, da Rosa MM, Leão HI, Silva EDL, Ferreira NT, Albuquerque APB, Duarte GS, Siqueira AM, Pereira MC, Rêgo MJBM, Pitta MGR. Brain damage serum biomarkers induced by COVID-19 in patients from northeast Brazil. J Neurovirol, 2023;31:1-7.
13. Choi JH, Chun BJ, Yeom SR, Chung SP, Lee YH, Kim YH, Lee JS, Lee JH, Lee HG, Jin JY, An CS, Gwag BJ. Rationale and methods of the antioxidant and NMDA receptor blocker weans anoxic brain damage of KorEa OHCA patients (AWAKE) trial. Trials, 2022;23(1):587.
14. Ertuğrul S, Darakci SM, Kaplan İ, Yolbaş İ, Deger İ, Tanrıverdi Yilmaz S, Aktaş Ş. The contribution of postnatal steroid administration to early brain damage in preterm babies with bronchopulmonary dysplasia. Turk J Med Sci, 2021;51(4):1917-1923.
15. Bagheri M, Ghaneialvar H, Oshnokhah M, Salari S. GFAP and neuron specific enolase (NSE) in the serum of suicide attempters. Med J Islam Repub Iran, 2022;36:103.
16. Friis T, Wikström AK, Acurio J, León J, Zetterberg H, Blennow K, Nelander M, Åkerud H, Kaihola H, Cluver C, Troncoso F, Torres-Vergara P, Escudero C, Bergman L. Cerebral biomarkers and blood-brain barrier integrity in preeclampsia. Cells, 2022;11(5):789.
17. Zhou S, Li Y, Hong Y, Zhong Z, Zhao M. Puerarin protects against sepsis-associated encephalopathy by inhibiting NLRP3/Caspase-1/GSDMD pyroptosis pathway and reducing blood-brain barrier damage. Eur J Pharmacol, 2023;945:175616.
18. Sorokina EG, Semenova ZB, Reutov VP, Arsenieva EN, Karaseva OV, Fisenko AP, Roshal LM, Pinelis VG. Brain biomarkers in children after mild and severe traumatic brain injury. Acta Neurochir Suppl, 2021;131:103-107.
19. Elsharkawy RE, Abdel Azim GS, Osman MA, Maghraby HM, Mohamed RA, Abdelsalam EM, Ebrahem EE, Seliem NMA. Peripheral polyneuropathy and cognitive impairment in type II diabetes mellitus. Neuropsychiatr Dis Treat, 2021;17:627-635.
20. Said MF, Islam AA, Massi MN, Prihantono. Effect of erythropoietin administration on the expression of brain-derived neurotrophic factor, stromal cell-derived Factor-1, and neuron-specific enolase in traumatic brain injury: a literature review. Ann Med Surg (Lond), 2021;69:102666.
21. Huang J, Sun X, Wang H, Chen R, Yang Y, Hu J, Zhang Y, Gui F, Huang J, Yang L, Hong Y. Conditional overexpression of neuritin in supporting cells (SCs) mitigates hair cell (HC) damage and induces HC regeneration in the adult mouse cochlea after drug-induced ototoxicity. Hear Res, 2022;420:108515.
22. Song D, Li G, Hong Y, Zhang P, Zhu J, Yang L, Huang J. miR‑199a decreases Neuritin expression involved in the development of Alzheimer’s disease in APP/PS1 mice. Int J Mol Med, 2020;46(1):384-396.
23. Du W, Gao A, Herman JG, Wang L, Zhang L, Jiao S, Guo M. Methylation of NRN1 is a novel synthetic lethal marker of PI3K-Akt-mTOR and ATR inhibitors in esophageal cancer. Cancer Sci, 2021;112(7):2870-2883.
24. da Rosa N, de Medeiros FD, de Oliveira J, Laurentino AOM, Peretti EM, Machado RS, Lourenço MP, da Silva TI, Fernandes TDC, Reis PA, de Castro Faria Neto HC, Prophiro JS, Fortunato JJ, Petronilho F. 6-Shogaol exerts a neuroprotective factor in offspring after maternal immune activation in rats. Dev Neurosci, 2022;44(1):13-22.
25. Lauwers M, Frikha A, Fage D, Duterme C, De Vos N, Cotton F, Wolff F. Development and validation of a simple correction method for the measurement of neuron-specific enolase in hemolyzed serum samples. Scand J Clin Lab Invest, 2022;82(1):12-17.
26. Lin Z, Wan G, Wu J, Liu H, Zhang F, Tang X, Ruan J. Toxicologic effect of short-term enrofloxacin exposure on brain of Carassius auratus var. Pengze. Sci Total Environ, 2023;869:161730.
Copyright (c) 2024 Bingbing Pu
This work is licensed under a Creative Commons Attribution 4.0 International License.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.